Trait selection via third‑party analytics

Even if testing labs restrict reports to health risks, companies can accept the raw embryo genotypes and generate predictions for traits like IQ, height, and eye color. This 'middleware' model functionally delivers designer‑style selection without the primary lab offering it. — It reveals a regulatory loophole that shifts governance from test providers to data flows, forcing policymakers to regulate downstream analytics and consent rather than only lab menus.